Humacyte, Inc. (HUMAW) NASDAQ

0.10

-0.0005(-0.50%)

Updated at December 24 12:35PM

Currency In USD

Valuation

Market Cap598.32M
Enterprise Value569.92M
P/E Ratio-9.19
PEG Ratio-0.19
Price/Sales Ratio18.34
Price/Book Ratio-37.65
Enterprise/Revenue19.52
Enterprise/EBITDA-29.24

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-2.21
Operating Margin-11.98

Management Effectiveness

Return On Assets-0.21
Return On Equity4.49

Income Statement

Revenue0
Revenue/Share0.06
Gross Profit-7.19M
EBITDA-132.23M
Net Income-148.7M
Diluted EPS-1.26

Balance Sheet

Total Cash19.49M
Total Cash/Share0.12
Total Debt29.83M
Total Debt/Equity-6.28
Current Ratio1.62
Book Value Per Share-0.03

Price History

52-Week Change-94.59
52-Week High0.23
52-Week Low0.09
Moving Average 50 Days0.18
Moving Average 200 Days0.38

Statistics

Average Volume19,678.5
Shares Outstanding1.2B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A